condit
ligand
enabl
highthroughput
product
human
leukocyt
antigen
hla
librari
present
defin
peptid
immunomonitor
platform
typic
concentr
restrict
element
associ
european
ancestri
tool
scarc
asian
hla
variant
report
novel
irradiationsensit
ligand
specif
target
south
east
asian
popul
provid
coverag
hlaa
b
c
respect
uniqu
ligand
hla
type
construct
provid
desir
solubl
hla
product
suffici
yield
peptid
exchang
accomplish
variant
demonstr
elisabas
mhc
stabil
assay
hla
tetram
redirect
specif
could
detect
antigenspecif
tcell
respons
human
cytomegaloviru
hepat
b
hbv
dengu
viru
denv
epsteinbarr
viru
ebv
infect
potenti
populationcentr
hla
librari
demonstr
character
seven
novel
tcell
epitop
sever
acut
respiratori
syndrom
coronaviru
hbv
denv
posthoc
analysi
reveal
major
respons
would
readili
identifi
unbias
discoveri
approach
applic
stateoftheart
epitop
predict
flow
cytometrybas
technolog
therefor
hold
consider
promis
monitor
clinic
relev
antigenspecif
tcell
respons
popul
distinct
ethnic
keyword
tcell
respons
r
condit
ligand
r
epitop
map
r
hla
polymorph
r
immunotechnolog
addit
support
inform
may
found
onlin
version
articl
publish
websit
antigenspecif
tcell
recogn
infect
neoplast
cell
respond
target
lysi
product
cytokin
prolifer
divers
set
effector
function
gener
contribut
clearanc
infect
also
lead
immunopatholog
circul
lymphocyt
deriv
specif
highli
variabl
clonal
distribut
tcell
receptor
tcr
inspect
class
major
histocompat
complex
mhc
glycoprotein
composit
surfac
survey
molecul
consist
intracellularli
deriv
antigen
peptid
ligand
present
protein
heterodim
compris
mhc
heavi
chain
well
invari
microglobulin
light
chain
human
class
gene
product
human
leukocyt
antigen
hla
famili
restrict
element
classic
transplant
antigen
encod
three
separ
loci
ie
hlaa
b
c
highli
polymorph
hla
variabl
geograph
distribut
significantli
correl
allel
variant
mark
distinct
ethnic
group
consequ
host
ethnic
shape
fine
specif
tlymphocyt
reactiv
sever
viral
afflict
ebv
hepat
b
hbv
hcv
hiv
monitor
tcellmedi
immun
respons
mhc
multim
reagent
success
exploit
identif
enumer
phenotyp
character
isol
cell
sever
methodolog
emerg
manag
variabl
affect
mhc
antigen
present
enabl
multiparametr
analysi
antigenspecif
tcell
respons
combinatori
code
mhc
multim
exampl
allow
parallel
detect
multipl
tcell
specif
use
limit
number
fluorochrom
highthroughput
flow
cytometri
anoth
technolog
breakthrough
came
develop
condit
ligand
hla
complex
murin
mhc
facilit
product
peptidemhc
reagent
divers
specif
common
precursor
peptideexchang
strategi
origin
reagent
design
archetyp
hlaa
later
expand
b
well
b
therebi
provid
signific
coverag
western
european
popul
half
world
popul
howev
inhabit
region
within
asia
oceania
origin
world
popul
data
sheet
http
paradox
accur
definit
tcell
epitop
asian
hla
variant
long
trail
european
counterpart
therefor
report
peptideexchang
technolog
seven
hlaa
five
hlab
four
hlac
restrict
element
commonli
associ
asian
ancestri
enabl
comprehens
assess
correspond
tcell
respons
demonstr
util
diagnost
reagent
precis
definit
novel
antigen
deriv
infecti
agent
dengu
viru
denv
sever
acut
respiratori
syndrom
coronaviru
sarscov
hbv
relev
south
east
asian
sea
popul
discoveri
pipelin
compris
initi
enzymelink
immunosorb
spot
elispot
screen
pool
overlap
peptid
cage
hla
complex
subsequ
facilit
rapid
determin
peptid
fine
specif
hla
restrict
thu
allevi
epitop
discoveri
bottleneck
conserv
pbmc
sampl
process
retrospect
assess
screen
demonstr
major
epitop
would
discov
select
restrict
element
antigen
protein
consid
bioinformat
select
peptid
appli
restrict
commonli
impos
condit
ligand
introduc
toeb
et
al
uvlight
sensit
phenylpropion
acid
group
anp
j
incorpor
hlabind
peptid
longwav
uv
exposur
trigger
photolysi
anp
residu
result
fragment
ligand
affect
amino
acid
complex
sever
design
publish
variabl
peptidebind
motif
often
prohibit
interchang
use
hla
product
aim
develop
condit
ligand
princip
sea
variant
consist
hlaa
b
b
b
b
b
c
c
c
c
cover
major
hlaa
b
c
molecul
allel
frequenc
asia
fig
neglig
occurr
caucasian
fact
b
c
c
domin
sea
popul
allel
frequenc
least
higher
europ
select
parent
peptid
support
inform
tabl
pertin
hla
strateg
amino
acid
substitut
aim
gener
ligand
unperturb
hla
affin
sever
design
test
fig
support
inform
fig
anp
introduct
central
posit
peptid
endeavor
effect
liber
peptidebind
cleft
uvinduc
fragment
synthesi
ident
condit
ligand
ascertain
lcm
analysi
support
inform
fig
peptid
subsequ
refold
correspond
heavi
light
chain
biotinyl
purifi
sizeexclus
chromatographi
produc
hla
monom
although
compar
yield
contenti
refold
concern
distinct
molecular
complex
sever
trend
discern
exampl
hlaa
product
averag
yield
approxim
mgl
outperform
hlab
furnish
approxim
mgl
variat
could
high
hla
product
provid
highest
mgl
mgl
lowest
yield
presum
reflect
differ
ligand
affin
well
overal
stabil
complex
analog
design
parent
peptid
differ
could
observ
mgl
mgml
highest
yield
condit
ligand
hla
select
follow
experi
fig
condit
ligand
permit
manipul
hla
peptid
cargo
exploit
defin
hla
restrict
peptid
finespecif
novel
tcell
epitop
see
without
consum
valuabl
peripher
blood
mononuclear
cell
pbmc
sampl
evalu
structur
integr
hla
complex
monitor
presenc
noncoval
associ
subunit
vitro
hlastabl
elisa
allow
us
verifi
extent
hla
disintegr
variou
stage
photocleavag
reaction
indic
effect
peptid
exchang
pertin
hla
appreci
degrad
condit
ligandload
complex
observ
absenc
uv
irradi
fig
exposur
uv
light
result
nearquantit
loss
signal
major
hla
product
examin
howev
c
c
display
except
stabil
still
present
cleavag
fig
reminisc
product
yield
complex
fig
uv
fragment
unfold
aggreg
precipit
complex
could
prevent
inclus
peptid
capabl
reoccupi
peptidebind
groov
thu
confer
stabil
deliv
novel
specif
process
antigen
deriv
ebv
human
cytomegaloviru
hbv
denv
tabl
immobil
hla
complex
probe
antihuman
antibodi
presenc
noncoval
associ
subunit
horseradish
peroxidas
catalyz
azinobi
acid
develop
track
measur
absorb
nm
independ
assay
conduct
hla
variou
peptid
effici
stabil
hla
black
bar
other
capabl
maintain
integr
white
bar
indic
data
normal
shown
mean
sem
four
replic
measur
repres
three
experi
perform
influenza
viru
conform
report
restrict
element
restor
complex
least
two
separ
ligand
prove
feasibl
individu
exchang
reaction
fig
support
inform
tabl
howev
peptid
lack
proper
complementar
fail
rescu
hla
uv
irradi
especi
mismatch
hla
supertyp
exampl
ebvderiv
clgglltmv
restrict
ie
supertyp
prove
unabl
conserv
integr
b
hla
micropolymorph
also
affect
peptid
bind
env
flltkilti
pol
glsryvarl
associ
well
env
prove
capabl
stabil
close
relat
variant
fig
collect
demonstr
success
temporari
stabil
peptideexchang
use
condit
ligand
tailor
asian
hla
variant
although
empti
hla
product
could
rescu
decay
question
remain
whether
result
complex
present
antigen
cargo
indistinguish
natur
load
hla
address
stain
antigenspecif
tcell
popul
asian
hla
tetram
recruit
healthi
volunt
genotyp
hlaa
b
c
allel
support
inform
tabl
fluoresc
label
hla
tetram
ebv
human
cytomegaloviru
hbv
denv
influenza
viru
epitop
gener
uvexchang
support
inform
tabl
hlamatch
tetram
use
direct
ex
vivo
stain
fresh
pbmc
healthi
volunt
donor
respond
ebv
epitop
gqggsptam
flow
analysi
ex
vivo
isol
cell
reveal
major
sampl
detect
respons
support
inform
fig
b
hla
tetram
stain
virusspecif
cell
pbmc
healthi
donor
pbmc
expand
day
respect
peptid
except
flpdffpsvspecif
cell
engin
tcr
gene
transfer
lymphocyt
cell
stain
viabil
well
hla
tetram
present
peptid
use
stimul
costain
antihuman
antibodi
number
shown
flow
cytometri
analysi
percentag
total
live
cell
gate
quadrant
cell
topright
quadrant
repres
hla
tetram
doubleposit
cell
complet
hla
genotyp
pbmc
donor
list
support
inform
tabl
data
shown
repres
least
two
independ
experi
peptidehla
combin
except
distinct
hlaa
avfdrksdak
tetram
posit
popul
total
cell
therefor
enrich
antigenspecif
cell
vitro
cultur
day
follow
antigen
stimul
amplif
allow
visual
antigenspecif
cell
hla
tetram
day
support
inform
fig
propag
lymphocyt
success
visual
b
b
b
tetram
repres
signific
proport
averag
cell
well
separ
princip
popul
fig
specif
tcell
first
observ
day
poststimul
hlab
tetram
could
also
detect
b
tetram
moreov
subject
hlaa
restrict
flpsdffpsvspecif
cell
engin
tcr
gene
transfer
stain
hlaa
tetram
load
hbv
core
peptid
evalu
capac
tcr
discrimin
micropolymorph
subtyp
common
sea
popul
fig
crossspecif
recognit
observ
hlaa
present
hbv
peptid
yet
posit
stain
obtain
hlaa
tetram
dearth
known
epitop
asian
hla
variant
preclud
confirm
tetram
function
hlaa
b
hlacrestrict
respons
similarli
absent
donor
cohort
valid
hla
tetram
librari
employ
antigen
identif
epitop
asian
variant
scarc
compar
caucasian
counterpart
often
fulli
character
regard
fine
specif
hla
restrict
screen
tcell
respons
individu
histori
acut
hbv
exposur
denv
sarscov
pbmc
vitro
stimul
peptid
pool
overlap
ten
amino
acid
thu
cover
entir
viral
proteom
peptid
hbv
genotyp
b
peptid
sarscov
np
peptid
protein
peptid
secret
first
assess
elispot
posit
pool
deconvolut
stimul
pbmc
individu
peptid
follow
measur
product
intracellular
cytokin
stain
identifi
novel
tcell
respons
deriv
hbv
polymeras
denv
nonstructur
protein
summar
fig
togeth
antigen
embed
sarscov
nucleocapsid
protein
base
hla
genotyp
shortterm
tcell
line
support
inform
tabl
hlabind
motif
anticip
restrict
element
hbv
line
b
denv
line
b
sarscov
peptid
known
present
b
b
respect
move
away
infer
hla
restrict
panel
peptidepuls
b
lymphoblastoid
cell
line
blcl
consumpt
sampl
deriv
distinct
overlap
peptid
epitop
support
inform
fig
hlastabl
elisa
allow
us
rapidli
screen
abil
peptid
rescu
variou
hla
complex
denatur
sar
exampl
three
embed
peptid
restrict
either
b
fig
sarscov
denv
hbv
antigen
found
least
one
peptid
set
stabil
hla
product
librari
mostli
bound
anticip
hla
support
inform
fig
often
posit
cterminu
parent
peptid
fig
underscor
import
overlap
peptid
screen
approach
confirm
fine
specif
hla
restrict
curtail
list
peptid
tetram
stain
employ
sar
tcell
line
found
peptid
ie
getalall
getalalll
stabil
b
fig
yet
cell
line
stain
posit
b
tetram
load
fig
frequent
observ
extens
contract
singl
amino
detriment
hla
bind
peptid
yet
optim
epitop
recogn
correspond
tcr
shortterm
expand
sarscov
denv
hbv
line
stain
correspond
b
b
b
tetram
fig
pbmc
unrel
control
fig
sar
hbv
line
peptid
preselect
elisa
fail
yield
function
stain
reagent
comprehens
tetram
screen
truncat
peptid
howev
reveal
sitaqpvki
flgpllvlqa
optim
antigen
present
b
c
respect
seven
character
epitop
tabl
cell
bound
hla
counterpart
moder
affin
judg
mfi
shift
individu
tetram
b
hbv
hbv
display
c
provid
stain
antigenspecif
cell
clearli
resolv
main
tcell
popul
function
line
establish
product
tabl
data
getalallllspecif
cell
report
surfac
express
upon
peptid
stimul
confirm
hlatetram
result
fig
deliber
chose
employ
bioinformat
predict
select
candid
antigen
even
though
adopt
commonplac
curiou
assess
whether
stateoftheart
algorithm
could
reproduc
outcom
discoveri
effort
select
netmhcpan
abil
comput
bind
capabl
peptid
even
hla
product
experiment
data
scarc
ii
accommod
epitop
variabl
length
iii
publicli
access
perform
ic
predict
possibl
epitop
encompass
sarscov
hbv
denv
peptid
hla
variant
donor
genotyp
data
inclus
impos
nm
affin
threshold
less
stringent
convent
ic
cutoff
nm
provid
estim
specif
sensit
peptid
rank
ic
valu
experiment
deriv
epitop
rank
determin
within
complet
hla
constel
pbmc
donor
well
correct
restrict
element
tabl
even
liber
strategi
would
instantli
preclud
discoveri
two
novel
epitop
peptid
sitaqpvki
flgpllvlqa
predict
bind
hlab
hlac
respect
ic
valu
fold
cutoff
moreov
predict
misguid
flgpllvlqa
predict
affin
hlaa
nm
true
restrict
element
hlac
ic
nm
would
exclud
consider
given
predict
method
aim
reduc
magnitud
peptid
collect
investig
full
proteomebas
bioinformat
screen
encompass
peptid
overlap
peptid
librari
scenario
total
number
peptid
screen
netmhcpan
would
equal
collect
elispot
screen
ie
peptid
hbv
peptid
sarscov
peptid
denv
condit
tetram
reagent
develop
compris
differ
hla
molecul
includ
report
hlaa
therefor
number
highest
rank
peptid
screen
per
hla
hbv
eight
sarscov
denv
follow
criteria
three
seven
novel
epitop
would
discov
base
hlaspecif
rank
ie
sitaqpvki
sviwmmwyw
flgpllvlqa
tabl
netmhcpan
algorithm
would
employ
curtail
peptid
collect
half
size
elispot
screen
peptid
screen
per
hla
would
nine
hbv
four
sarscov
denv
major
novel
antigen
ie
mevtpsgtwl
sitaqpvki
sviwmmwyw
flgpllvlqa
would
miss
although
method
might
well
outperform
individu
allelespecif
predict
submit
employ
netmhcpan
appropri
strategi
pbmc
donor
cohort
high
hla
polymorph
particularli
popul
preponder
class
hla
variant
limit
experiment
verifi
data
avail
expos
current
limit
deploy
predict
algorithm
valid
approach
use
overlap
peptid
librari
togeth
highthroughput
tetram
screen
identifi
character
novel
tcell
epitop
monitor
cellular
immun
respons
requir
disentangl
heterogen
basi
variou
diagnost
therapeut
applic
condit
ligand
integr
use
mhcbase
multim
array
highthroughput
flow
cytometr
analysi
antigenspecif
cell
allow
rapid
synthesi
mhc
molecul
distinct
specif
peptideexchang
protocol
strategi
appli
screen
class
mhcassoci
antigen
sought
extend
technolog
specif
asian
popul
therefor
design
synthes
uvlight
sensit
condit
ligand
construct
correspond
hla
molecul
thu
expand
portfolio
condit
ligandload
hla
nearli
threefold
first
time
includ
hlac
allel
variant
despit
polymorph
natur
hla
librari
includ
major
allel
asia
fig
world
popul
region
stabil
complex
valid
hla
variant
prove
cooper
ligand
replac
fig
correspond
tetram
could
also
detect
common
virusspecif
tlymphocyt
respons
healthi
volunt
fig
identif
novel
epitop
asian
hla
variant
combin
elispot
condit
ligandbas
assay
ie
hlastabl
elisa
hla
tetram
array
therebi
build
key
featur
technolog
afford
circumv
limit
elispot
assay
quantifi
activ
secret
cytokin
recogn
high
sensit
compar
assay
beadbas
assay
intracellular
cytokin
stain
also
permit
screen
pool
overlap
peptid
usag
clinic
sampl
econom
lymphocyt
maintain
viabil
make
amen
highthroughput
proteomewid
antigen
screen
ongo
epitop
identif
effort
hbv
sarscov
denv
infect
identifi
seven
peptid
capabl
stimul
tcell
respons
singaporean
donor
fig
hla
restrict
fine
specif
epitop
would
commonli
infer
cellular
assay
howev
suffer
simultan
express
variou
hla
variant
complic
data
interpret
use
cage
asian
hla
measur
recept
accommod
shorter
peptid
embed
parent
antigen
rapidli
pinpoint
like
antigen
sequenc
util
low
amount
hla
reagent
spare
preciou
pbmc
sampl
ultim
confirm
peptid
fine
specif
hla
restrict
element
respons
engend
tcell
respons
provid
stain
array
hla
tetram
allow
rapid
visual
quantif
vitro
cultur
cryopreserv
sampl
freshli
isol
antigenspecif
cell
high
specif
sensit
hla
tetram
thu
permit
monitor
isol
antigenspecif
lymphocyt
usag
extend
screen
novel
tcell
antigen
seven
seven
time
antigen
epitop
correctli
identifi
valid
approach
reduc
number
epitop
biophys
mean
construct
peptideexchang
hla
librari
give
suffici
coverag
epitop
screen
asia
probabl
match
hla
profil
lymphocyt
donor
least
one
cage
hla
high
sea
hlaa
b
c
well
close
relat
popul
oceania
hlaa
b
c
contrast
european
hlaa
b
c
north
american
region
hlaa
b
c
equival
molecul
alreadi
design
similar
effort
subsaharan
africa
hlaa
b
c
southwest
asia
hlaa
b
c
hla
divers
pronounc
would
need
suit
reagent
proport
extend
final
found
retrospect
analysi
bioinformat
strategi
predict
hlarestrict
epitop
would
like
fail
identifi
consider
portion
novel
tcell
epitop
describ
herein
advanc
cytometri
compel
hla
tetram
technolog
keep
pace
equival
improv
higher
dimension
stain
distinct
antigenspecif
tcell
subset
becom
feasibl
label
hla
multim
uniqu
combinatori
code
pass
cell
microarray
platform
onsurfac
inspect
emerg
technolog
label
cell
surfac
marker
heavi
metal
ion
cytof
analysi
among
advantag
elimin
need
fluoresc
compens
enabl
simultan
immunophenotyp
track
larg
cellular
subset
variou
patholog
tcell
immun
strongli
correl
protect
explor
therapeut
valu
warrant
increasingli
met
clinic
success
redirect
cell
target
viral
infect
malign
cell
may
gener
either
vitro
expans
autolog
lymphocyt
genet
modif
drive
tcr
express
desir
specif
infus
patient
develop
reli
accur
definit
antigenspecif
tlymphocyt
respons
hla
librari
asian
variant
report
essenti
character
enumer
clinic
relev
antigenspecif
cell
condit
ligand
manual
construct
standard
fmocbas
solidphas
peptid
synthesi
deprotect
amino
acid
side
chain
releas
resin
achiev
trifluoroacet
acid
water
triisopropyl
silan
follow
precipit
cold
diethyl
ether
peptid
ident
confirm
ittof
lcm
analysi
shimadzu
peptid
use
screen
suppli
crude
lyophil
form
mimotop
suppli
lyophil
form
puriti
genscript
dissolv
dimethyl
sulfoxid
sigmaaldrich
milliq
water
contain
mm
tri
phosphin
sigmaaldrich
store
c
hla
product
produc
describ
briefli
gene
codonoptim
escherichia
coli
support
inform
tabl
plasmid
encod
human
hlaheavi
chain
synthes
genscript
heavi
chain
contain
ctermin
birasequ
overexpress
e
coli
upon
isopropyl
induct
protein
isol
inclus
bodi
denatur
urea
solubil
heavi
light
chain
mix
molar
excess
condit
ligand
h
dialyz
mm
triscl
buffer
ph
concentr
enzymat
biotinyl
bira
hla
monom
purifi
sizeexclus
chromatographi
conjug
streptavidinp
allophycocyanin
molar
ratio
hla
tetram
dilut
pb
contain
replac
peptid
follow
long
wave
nm
uv
exposur
ultraviolet
crosslink
uvp
h
incub
tetram
centrifug
rpm
supernat
use
cell
stain
hlab
condit
ligand
exchang
replac
peptid
hla
tetram
gener
concentr
follow
establish
protocol
micropl
corn
coat
streptavidin
invitrogen
pb
h
c
wash
pbstween
sigmaaldrich
two
percent
bsa
pb
ad
incub
min
room
temperatur
rt
peptid
exchang
initi
min
uv
irradi
perform
tube
contain
peptid
recombin
hla
pb
c
solut
dilut
nm
hla
ad
well
incub
h
c
plate
wash
tween
pb
hrpconjug
antibodi
clone
abcam
ad
follow
h
incub
c
plate
wash
abt
solut
invitrogen
ad
min
develop
rt
reaction
stop
sodium
azid
sigmaaldrich
citric
acid
absorb
nm
measur
use
spectramax
molecular
devic
approv
studi
protocol
conform
principl
set
wma
declar
helsinki
nih
belmont
report
provid
institut
review
board
nation
univers
singapor
healthi
volunt
recruit
written
inform
consent
hlagenotyp
blood
donat
suitabl
hlatyp
collect
pbmc
isol
fresh
heparin
blood
ficollhypaqu
centrifug
cell
ml
cultur
human
ab
serum
invitrogen
autolog
plasma
rpmi
media
contain
mm
lglutamin
invitrogen
supplement
sigmaaldrich
iuml
penicillinstreptomycin
invitrogen
c
co
antigen
peptid
ad
uml
r
system
inc
ad
day
poststimul
half
media
chang
supplement
done
everi
day
sarscovspecif
tcell
line
hbv
core
tcrredirect
tcell
obtain
previou
studi
hbv
hbv
line
denv
denv
line
develop
follow
shortterm
tcell
line
grown
frozen
pbmc
previous
stimul
peptid
restimul
ebvtransform
bcell
puls
media
h
cell
cultur
gammairradi
feeder
pbmc
peptidepuls
ebvtransform
b
cell
aimv
medium
invitrogen
pool
human
ab
serum
supplement
uml
ngml
ngml
r
system
day
c
co
line
upregul
produc
h
peptid
stimul
use
epitop
character
ebvderiv
specif
cell
obtain
donor
recruit
previou
studi
enrich
specif
cell
pbmc
puls
gqggsptam
h
rt
xvivo
medium
lonza
without
serum
afterward
cell
cultur
xvivo
human
serum
cellsml
incub
c
co
ad
total
concentr
uml
peprotech
follow
day
cell
cultur
day
pbmc
wash
pb
cell
viabil
ascertain
livedead
r
fixabl
nearir
stain
invitrogen
prior
tetram
stain
cell
wash
stain
peor
allophycocyaninconjug
hla
tetram
pb
sodium
azid
ice
min
cell
subsequ
stain
blue
tm
clone
bd
bioscienc
clone
bd
bioscienc
min
wash
fix
paraformaldehyd
pb
cell
donor
stain
concentr
peconjug
hla
tetram
c
min
follow
addit
antibodi
mix
consist
fluor
clone
biolegend
clone
respect
bd
clone
serotech
viabil
marker
livedead
r
fixabl
nearir
stain
invitrogen
min
c
data
acquir
bd
lsrii
flow
cytomet
bd
bioscienc
analyz
use
flowjo
treestar
inc
support
inform
fig
display
gate
strategi
appli
cell
grown
ml
rpmi
invitrogen
supplement
pool
human
ab
serum
invitrogen
antibodi
clone
bd
bioscienc
brefeldin
sigmaaldrich
ad
follow
stimul
peptid
mix
ngml
pma
ngml
ionomycin
sigmaaldrich
h
c
co
cell
wash
hla
tetram
surfacemark
stain
perform
intracellular
cytokin
stain
done
use
antihuman
antibodi
clone
r
system
human
intracellular
cytokin
stain
starter
kit
bd
bioscienc
accord
manufactur
specif
algorithm
use
predict
ic
valu
peptid
found
proteom
hbv
denv
sarscov
includ
core
x
envelop
polymeras
protein
hbv
genotyp
b
ncbi
access
well
hbv
genotyp
b
ncbi
access
hbv
genotyp
c
ncbi
access
envelop
protein
furthermor
capsid
membran
glycoprotein
envelop
protein
protein
k
peptid
denv
ncbi
access
nc
np
protein
sarscov
ncbi
access
includ
predict
made
hlaa
b
c
allel
per
donor
output
ic
peptid
affin
threshold
nm
enabl
rank
